Alluvi Retatrutide 40mg pen — Premium High-Dose Triple-Incretin Formula

Alluvi Retatrutide 40mg pen formulation delivering triple GLP-1, GIP and Glucagon activation for elite fat-loss research.

Concentration & Quality

• 40 mg Retatrutide per prefilled pen
• Triple-receptor agonist ( GLP-1 + GIP + Glucagon )
• Alluvi pharmaceutical-grade precision manufacturing

Key Features

• Highest strength Retatrutide on the market
• Triple pathway activation for maximum metabolic efficiency
• Extended duration of action for prolonged studies

How to Use

Prefilled pen. Store refrigerated (2–8 °C). For research use only.

How It Works

Retatrutide activates GLP-1, GIP and Glucagon receptors, enhancing appetite suppression and energy expenditure. The Alluvi 40 mg dose delivers sustained incretin activation for advanced metabolic research.

Storage & Handling

Keep refrigerated (2–8 °C). Protect from light. Avoid freezing.